Home›Foscarnet Sodium›Foscarnet Sodium + Methotrexate

Does Foscarnet Sodium Interact with Methotrexate?

CDI records a major classification for Foscarnet Sodium and Methotrexate. The stored summary is: Concomitant use should be avoided due to additive nephrotoxicity and renal impairment risk. The mechanism involves both drugs cause renal impairment. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Methotrexate Class
Folate Analog Metabolic Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

Both drugs cause renal impairment

What To Tell Your Doctor or Pharmacist

If you are taking Foscarnet Sodium and your doctor is considering prescribing Methotrexate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Foscarnet Sodium(Foscavir)+💊 Methotrexate(Otrexup)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Folate Analog Metabolic Inhibitor
Source
NLP:foscarnet sodium

What this means in plain English

Concomitant use should be avoided due to additive nephrotoxicity and renal impairment risk.

About Foscarnet Sodium and Methotrexate

Methotrexate is a Folate Analog Metabolic Inhibitor. You may recognize them by the brand names Foscavir and Otrexup. Both Foscarnet Sodium and Methotrexate carry an FDA boxed warning — the agency's most serious safety designation.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:foscarnet sodium

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Foscarnet Sodium and Methotrexate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations